Search Results - "Filloon, Thomas"
-
1
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial
Published in Circulation (New York, N.Y.) (09-09-2003)“…Complement, activated during myocardial ischemia and reperfusion, causes myocardial damage through multiple processes. The COMplement inhibition in Myocardial…”
Get full text
Journal Article -
2
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial
Published in Circulation (New York, N.Y.) (09-09-2003)“…Complement activation mediates myocardial damage that occurs during ischemia and reperfusion through multiple pathways. We performed 2 separate, parallel,…”
Get full text
Journal Article -
3
Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves
Published in The Journal of thoracic and cardiovascular surgery (01-02-2005)“…Recent consensus statements recommend cardiac enzyme release as the essential criterion for diagnosing myocardial infarction. However, the outcome implications…”
Get full text
Journal Article -
4
Macular pigment optical density in a midwestern sample
Published in Ophthalmology (Rochester, Minn.) (01-04-2001)“…To assess the distribution of the macular pigments (MPs) lutein (L) and zeaxanthin (Z) in a healthy sample more representative of the general population than…”
Get more information
Journal Article -
5
Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview
Published in The American heart journal (01-08-2006)“…Recent trials evaluating the C5 complement inhibitor, pexelizumab, have shown that modulation of inflammation during ischemia/reperfusion in patients with…”
Get full text
Journal Article -
6
Performance Equivalence and Validation of the Soleris Automated System for Quantitative Microbial Content Testing Using Pure Suspension Cultures
Published in Journal of AOAC International (01-09-2016)“…Using United States Pharmacopeia-National Formulary (USP-NF) general method guidance, the Soleris(®) automated system and reagents (Nonfermenting Total Viable…”
Get full text
Journal Article -
7
Epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health
Published in International journal of dermatology (01-01-2011)“…Background Dandruff is a common scalp condition characterized by flakes, pruritus and sometimes mild erythema. These symptoms reflect underlying…”
Get full text
Journal Article -
8
Comparison of p-fluoroketorolac and [ 18O 3]ketorolac for use as internal standards for the determination of ketorolac by gas chromatography/mass spectrometry (GC/MS)
Published in Journal of pharmaceutical and biomedical analysis (01-06-1998)“…A chemical and a stable-isotope analog, p-fluoroketorolac and [ 18O 3]ketorolac respectively, were directly compared for applicability as internal standards…”
Get full text
Journal Article -
9
Scalp Stratum Corneum Histamine Levels: Novel Sampling Method Reveals Association with Itch Resolution in Dandruff/Seborrhoeic Dermatitis Treatment
Published in Acta dermato-venereologica (01-06-2011)“…Dandruff and seborrhoeic dermatitis are accompanied by bothersome itch. We have established a novel non-invasive methodology to sample histamine levels in the…”
Get full text
Journal Article -
10
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass
Published in The Annals of thoracic surgery (01-03-2004)“…During cardiac surgery requiring cardiopulmonary bypass, pro-inflammatory complement pathways are activated by exposure of blood to bio-incompatible surfaces…”
Get full text
Journal Article -
11
Gastrointestinal Symptoms Following Consumption of Olestra or Regular Triglyceride Potato Chips: A Controlled Comparison
Published in JAMA : the journal of the American Medical Association (14-01-1998)“…CONTEXT.— Olestra, a nonabsorbable, energy-free fat substitute used in snack foods, has been anecdotally reported to cause gastrointestinal (GI) adverse…”
Get full text
Journal Article -
12
Gastrointestinal Symptoms Following Olestra Consumption—Reply
Published in JAMA : the journal of the American Medical Association (22-07-1998)Get full text
Journal Article -
13
-
14
Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis
Published in The Journal of nutrition (01-03-2000)“…The associations between the intake of the fat-substitute olestra and the concentrations of macular carotenoid pigments and serum lutein and zeaxanthin were…”
Get more information
Journal Article -
15
Estimating the minimum therapeutically effective dose of a compound via regression modelling and percentile estimation
Published in Statistics in medicine (15-05-1995)“…Estimation of the minimum effective dose (MED) of a compound from a typical placebo-controlled dose-response study can be carried out in several ways. Current…”
Get more information
Journal Article -
16
Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing Olestra or triglycerides : A 6-week randomized, placebo-controlled trial
Published in Annals of internal medicine (16-02-1999)“…Olestra is a nonabsorbable, energy-free fat substitute. Because it is not absorbed, it may cause digestive symptoms when consumed in large amounts. To compare…”
Get full text
Journal Article -
17
Improving the sensitivity of in vitro skin penetration experiments
Published in Pharmaceutical research (01-12-1994)“…The institution of a readily-implemented sample screening and data handling procedure for in vitro skin penetration studies yields substantial improvements in…”
Get full text
Journal Article -
18
Randomized, Double-Blind, Placebo-Controlled, Consumer Rechallenge Test of Olean Salted Snacks
Published in Regulatory toxicology and pharmacology (01-10-1997)“…Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. A randomized, double-blind, placebo-controlled, within-subject, crossover…”
Get full text
Journal Article -
19
Improved curve estimation with smoothing splines through local cross-validation
Published 01-01-1991“…Much attention has been given recently to the nonparametric estimation of regression functions (or curves). Various methods have been shown to yield consistent…”
Get full text
Dissertation -
20
Improved curve estimation with smoothing splines through local cross-validation
Published 1991“…Much attention has been given recently to the nonparametric estimation of regression functions (or curves). Various methods have been shown to yield consistent…”
Get full text
Dissertation